Mark Andrew Sherman
CIK: 0001256708
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dolby Laboratories, Inc.
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Sep 15, 2026DLB
Dolby Laboratories, Inc.
Award(A)Direct48.1K shares- - Dec 17, 2025DLB
Dolby Laboratories, Inc.
Sale(S)Direct2.5K shares at avg. $67.26$168K - Dec 16, 2025DLB
Dolby Laboratories, Inc.
Sale(S)Direct2.4K shares at avg. $67.17$159K - Dec 16, 2025DLB
Dolby Laboratories, Inc.
Tax Payment(F)Direct2.5K shares at avg. $66.62$169K - Dec 16, 2025DLB
Dolby Laboratories, Inc.
Sale(S)Direct6.7K shares at avg. $66.58$449K - Dec 15, 2025DLB
Dolby Laboratories, Inc.
Award(A)Direct25.6K shares- - Dec 15, 2025DLB
Dolby Laboratories, Inc.
Exercise(M)Direct5.9K shares- - Dec 15, 2025DLB
Dolby Laboratories, Inc.
Tax Payment(F)Direct9.3K shares at avg. $67.54$625K - Dec 1, 2025DLB
Dolby Laboratories, Inc.
Sale(S)Direct4.5K shares at avg. $67.56$304K - Dec 1, 2025DLB
Dolby Laboratories, Inc.
Exercise(M)Direct4.5K shares at avg. $64.60$291K - Jun 4, 2025DLB
Dolby Laboratories, Inc.
Sale(S)Direct15K shares at avg. $75.02$1.1M - Jun 4, 2025DLB
Dolby Laboratories, Inc.
Exercise(M)Direct15K shares at avg. $64.60$969K - May 30, 2025DLB
Dolby Laboratories, Inc.
Sale(S)Direct350 shares at avg. $74.97$26K - Jan 30, 2025DLB
Dolby Laboratories, Inc.
Sale(S)Direct15K shares at avg. $83.00$1.2M - Jan 30, 2025DLB
Dolby Laboratories, Inc.
Sale(S)Direct25K shares at avg. $86.00$2.2M - Jan 30, 2025DLB
Dolby Laboratories, Inc.
Exercise(M)Direct40K shares at avg. $62.32$2.5M - Dec 17, 2024DLB
Dolby Laboratories, Inc.
Sale(S)Direct4.6K shares at avg. $77.83$360K - Dec 17, 2024DLB
Dolby Laboratories, Inc.
Sale(S)Direct7.7K shares at avg. $78.22$603K - Dec 16, 2024DLB
Dolby Laboratories, Inc.
Exercise(M)Direct5.2K shares- - Dec 16, 2024DLB
Dolby Laboratories, Inc.
Tax Payment(F)Direct8.9K shares at avg. $79.18$702K - Dec 16, 2024DLB
Dolby Laboratories, Inc.
Award(A)Direct20.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | DLB Dolby Laboratories, Inc. | Award(A) | 48,076 | - | $0 | Direct |
| Dec 17, 2025 | DLB Dolby Laboratories, Inc. | Sale(S) | 2,491 | $67.26 | $167,554 | Direct |
| Dec 16, 2025 | DLB Dolby Laboratories, Inc. | Sale(S) | 2,371 | $67.17 | $159,261 | Direct |
| Dec 16, 2025 | DLB Dolby Laboratories, Inc. | Tax Payment(F) | 2,530 | $66.62 | $168,549 | Direct |
| Dec 16, 2025 | DLB Dolby Laboratories, Inc. | Sale(S) | 6,738 | $66.58 | $448,588 | Direct |
| Dec 15, 2025 | DLB Dolby Laboratories, Inc. | Award(A) | 25,633 | - | - | Direct |
| Dec 15, 2025 | DLB Dolby Laboratories, Inc. | Exercise(M) | 5,915 | - | - | Direct |
| Dec 15, 2025 | DLB Dolby Laboratories, Inc. | Tax Payment(F) | 9,252 | $67.54 | $624,880 | Direct |
| Dec 1, 2025 | DLB Dolby Laboratories, Inc. | Sale(S) | 4,500 | $67.56 | $304,036 | Direct |
| Dec 1, 2025 | DLB Dolby Laboratories, Inc. | Exercise(M) | 4,500 | $64.60 | $290,700 | Direct |
| Jun 4, 2025 | DLB Dolby Laboratories, Inc. | Sale(S) | 15,000 | $75.02 | $1,125,287 | Direct |
| Jun 4, 2025 | DLB Dolby Laboratories, Inc. | Exercise(M) | 15,000 | $64.60 | $969,000 | Direct |
| May 30, 2025 | DLB Dolby Laboratories, Inc. | Sale(S) | 350 | $74.97 | $26,240 | Direct |
| Jan 30, 2025 | DLB Dolby Laboratories, Inc. | Sale(S) | 15,000 | $83.00 | $1,245,000 | Direct |
| Jan 30, 2025 | DLB Dolby Laboratories, Inc. | Sale(S) | 25,000 | $86.00 | $2,150,103 | Direct |
| Jan 30, 2025 | DLB Dolby Laboratories, Inc. | Exercise(M) | 40,000 | $62.32 | $2,492,800 | Direct |
| Dec 17, 2024 | DLB Dolby Laboratories, Inc. | Sale(S) | 4,625 | $77.83 | $359,986 | Direct |
| Dec 17, 2024 | DLB Dolby Laboratories, Inc. | Sale(S) | 7,713 | $78.22 | $603,317 | Direct |
| Dec 16, 2024 | DLB Dolby Laboratories, Inc. | Exercise(M) | 5,192 | - | $0 | Direct |
| Dec 16, 2024 | DLB Dolby Laboratories, Inc. | Tax Payment(F) | 8,867 | $79.18 | $702,089 | Direct |
| Dec 16, 2024 | DLB Dolby Laboratories, Inc. | Award(A) | 20,085 | - | $0 | Direct |
1-21 of 21 transactions
About SHERMAN MARK ANDREW
SHERMAN MARK ANDREW (SEC CIK 0001256708) files insider reports with the SEC as EVP, Gen. Counsel & Secretary of Dolby Laboratories, Inc. (DLB).
Signal8 holds 7 ownership filings by SHERMAN MARK ANDREW, all Form 4s, filed between Dec 18, 2024 and Sep 17, 2026. Those filings report 21 transactions, from Dec 16, 2024 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SHERMAN MARK ANDREW's filings is in SAN FRANCISCO, CA.
Recent filings by SHERMAN MARK ANDREW
- Sep 15, 2026: Grant or award of DLB shares (Form 4, code A).
- Dec 17, 2025: Open-market sale of DLB shares (Form 4, code S).
- Dec 16, 2025: Open-market sale of DLB shares (Form 4, code S).
- Dec 16, 2025: Tax withholding of DLB shares (Form 4, code F).
- Dec 16, 2025: Open-market sale of DLB shares (Form 4, code S).
Other insiders filing for Dolby Laboratories, Inc. (DLB)
- Couling John D, SVP, Entertainment
- Dolby Dagmar, 10% Owner
- Whitten Marc, President and CEO
- Nicholson Ryan, VP, CAO and Corp. Controller
- Revankar Shriram, SVP, Advanced Technology Group
- Pendleton Todd, SVP, Chief Marketing Officer